Neuroendocrinology
Ontogeny of Neuroendocrine Interactions
Brain-Derived Neurotrophic Factor But Not Neurotrophin-3 Enhances Differentiation of Somatostatin Neurons in Hypothalamic CulturesLoudes C. · Petit F. · Kordon C. · Faivre-Bauman A.INSERM U159, Paris, France
|
|
Log in to MyKarger to check if you already have access to this content.
KAB
Buy a Karger Article Bundle (KAB) and profit from a discount!
If you would like to redeem your KAB credit, please log in.
Save over 20% compared to the individual article price.
Article / Publication Details
Published online: September 27, 2000
Issue release date: September 2000
Number of Print Pages: 10
Number of Figures: 6
Number of Tables: 2
ISSN: 0028-3835 (Print)
eISSN: 1423-0194 (Online)
For additional information: https://www.karger.com/NEN
Abstract
The present work investigated whether neurotrophins could differentially affect in vitro growth and maturation of two related subsets of hypothalamic neurons, hypophysiotropic somatostatin (SRIH) neurons projecting from the periventricular area and arcuate SRIH interneurons. For this purpose, the hypothalamus of 17-day-old rat fetuses was sampled and separated into a ventral and a dorsal fragment containing respectively periventricular and arcuate regions. Each fragment was dissociated and seeded separately in defined medium. Brain-derived neurotrophic factor (BDNF) or neurotrophin-3 (NT-3), two important members of the neurotrophin family involved in neuronal differentiation and plasticity, were added to the cultures at seeding time. After 6 or 11 days in vitro, neurons were labeled with an anti-SRIH antiserum and submitted to morphometric analysis. In parallel, SRIH mRNA was estimated by semiquantitative reverse-transcriptase-polymerase chain reaction, and neuronal SRIH content, basal and depolarisation-stimulated releases measured by radioimmunoassay. The response of control, non-labeled neurons was estimated by neuronal counts and by assaying glutamic acid decarboxylase, a marker of a large majority of hypothalamic neurons. BDNF markedly increased the size and the branching number of SRIH periventricular cell bodies. Expression of SRIH mRNA, as well as SRIH content and release into the culture medium, were also stimulated by the neurotrophin. Non-SRIH neurons were not affected by the treatment. Under the same conditions, arcuate neurons exhibited a weak, mostly transient response to BDNF. NT-3 was ineffective on either neuronal subset. Immunoneutralization of Trk receptors provided further evidence for BDNF effect specificity. The results indicate that BDNF is a selective activator of the differentiation of hypophysiotropic SRIH neurons in the periventricular area of the hypothalamus.
© 2000 S. Karger AG, Basel
Related Articles:
References
-
Leibrock J, Lottspeich F, Hohn A, Hofer M, Hengerer B, Masiakowski P, Thoenen H, Barde Y-A: Molecular cloning and expression of brain-derived neurotrophic factor. Science 1989;341:149–152.
- Ernfors P, Ibanez CF, Ebendal T, Olson L, Persson H: Molecular cloning and neurotrophic activities of a protein with structural similarities to nerve growth factor: Developmental and topographical expression in the brain. Proc Natl Acad Sci USA 1990;87:5454–5458.
- Höhn A, Leibrock J, Bailey K, Barde Y-A: Identification and characterization of a novel member of the nerve growth factor/brain-derived neurotrophic family. Nature 1990;344:339–341.
- Jones KR, Reichardt LF: Molecular cloning of a human gene that is a member of the nerve growth factor family. Proc Natl Acad Sci USA 1990;87:8060–8064.
- Maisonpierre PC, Belluscio L, Squinto S, Ip NY, Furth ME, Lindsay RM, Yancopoulos GD: Neurotrophin-3: A neurotrophic factor related to NGF and BDNF. Science 1990;247:1446–1451.
- Snider WD: Functions of the neurotrophins during nervous system development: What the knockouts are teaching us. Cell 1994;77:627–638.
- Lu B, Figurov A: Role of neurotrophins in synapse development and plasticity. Rev Neurosci 1997;8:1–12.
- Friedman WJ, Olson L, Persson H: Cells that expressed brain-derived neurotrophic factor mRNA in the developing postnatal brain. Eur J Neurosci 1991;3:688–697.
- Castrén E, Thoenen H, Lindholm D: Brain-derived neurotrophic factor messenger RNA is expressed in the septum, hypothalamus and in adrenergic brain stem nuclei of adult brain and is increased by osmotic stimulation in the paraventricular nucleus. Neuroscience 1995;64:71–80.
- Katoh-Semba R, Takeuchi IK, Semba R, Kato K: Distribution of brain-derived neurotrophic factor in rats and its changes with development in the brain. J Neurochem 1997;69:34–42.
- Loudes C, Petit F, Kordon C, Faivre-Bauman A: Distinct populations of hypothalamic dopaminergic neurons exhibit differential responses to brain-derived neurotrophic factor (BDNF) and neurotrophin-3 (NT3). Eur J Neurosci 1999;11:617–624.
- Merlio J, Ernfors P, Jaber M, Persson H: Molecular cloning of rat trkC and distribution of cells expressing messenger RNAs for members of the trk family in the rat central nervous system. Neuroscience 1992;51:513–532.
- Berg-von der Emde K, Dees WL, Hiney JK, Hill DF, Dissen GA, Costa ME, Mohold-Siebert M, Ojeda S: Neurotrophins and the neuroendocrine brain: Different neurotrophins sustain anatomically and functionally segregated subsets of hypothalamic dopaminergic neurons. J Neurosci 1995;15:4223–4237.
- Marmigere F, Rage F, Tapia-Arancibia L, Arancibia S: Expression of mRNAs encoding BDNF and its receptor in adult rat hypothalamus. Neuroreport 1998;9:1159–1163.
- Rage F, Riteau B, Alonso G, Tapia-Arancibia L: Brain-derived neurotrophic factor and neurotrophin-3 enhance somatostatin gene expression through a likely direct effect on hypothalamic somatostatin neurons. Endocrinology 1999;140:909–916.
- Daikoku S, Hisano S, Kawano H, Okamura Y, Tsuruo Y: Ontogenetic studies on the topographical heterogeneity of somatostatin-containing neurons in rat hypothalamus. Cell Tissue Res 1985;242:511–518.
-
Shiosaka S: Ontogeny of the central somatostatinergic system; in Björklund A, Hökfelt TM (eds): Handbook of Chemical Neuroanatomy: Ontogeny of Transmitters and Peptides in the CNS. Amsterdam, Elsevier, 1992, vol 10, pp 369–398.
- Loudes C, Rougon G, Kordon C, Faivre-Bauman A: Polysialylated neural cell adhesion is involved in target-induced morphological differentiation of arcuate dopaminergic neurons. Eur J Neurosci 1997;9:2323–2333.
-
Faivre-Bauman A, Puymirat J, Loudes C, Tixier-Vidal A: Differentiated mouse foetal hypothalamic cells in serum-free medium; in Barnes DW, Sirbasku DA, Sato GH (eds): Methods for Serum-Free Culture of Neuronal and Lymphoid Cells. New York, Liss, 1984, pp 37–56.
- Maubert E, Ciofi P, Tramu G, Mazzuca M, Dupouy J: Early transient expression of somatostatin (SRIF) immunoreactivity in dorsal root ganglia during ontogenesis in the rat. Brain Res 1992;573:153–156.
- Grouselle D, Winsky-Sommerer R, David J-P, Delacourte A, Dournaud P, Epelbaum J: Loss of somatostatin-like immunoreactivity in the frontal cortex of Alzheimer patients carrying the apolipoprotein epsilon 4 allele. Neurosci Lett 1998;255:21–24.
- Heidet V, Faivre-Bauman A, Kordon C, Loudes C, Rasolonjanahary S, Epelbaum J: Functional maturation of somatostatin neurons and somatostatin receptors during development of mouse hypothalamus in vivo and in vitro. Dev Brain Res 1990;57:85–92.
-
Puymirat J, Faivre-Bauman A, Bizzini B, Tixier-Vidal A: Prenatal and postnatal ontogenesis of neurotransmitter-synthetizing enzymes and [125I]tetanus toxin binding capacity in the mouse hypothalamus. Dev Brain Res 1982;3:199–206.
External Resources
- Moskal JR, Basu S: The measurement of glutamate decorboxylase activity in brain tissues by a simple microradiometric method. Anal Biochem 1975;65:449–457.
- Peterson L: Simplification of the protein assay method of Lowry et al. which is more generally applicable. Anal Biochem 1977;83:346–356.
- René F, Poisbeau P, Egles C, Schlichter R, Félix JM: Co-culture of hypothalamic neurons and melanotrope cells: A model to study synaptogenesis between central neurons and endocrine cells. Neuroscience 1997;76:203–214.
- Marty S, Onténiente B: BDNF and NT-4 differentiate two pathways in the modulation of neuropeptide protein levels in postnatal hippocampal interneurons. Eur J Neurosci 1999;11:1647–1656.
- Barnea A, Cho G, Lu G, Mathis M: Brain-derived neurotrophic factor induces functional expression and phenotypic differentiation of cultured fetal neuropeptide Y-producing neurons. J Neurosci Res 1995;42:638–647.
- Nawa H, Carnahan J, Gall C: BDNF protein measured by a novel enzyme immunoassay in normal brain and after seizure: Partial disagreement with mRNA levels. Eur J Neurosci 1995;7:1527–1535.
- Kawamoto Y, Nakamura S, Nakano O, Oka N, Akiguchi I, Kimura J: Immunohistochemical localization of brain-derived neurotrophic factor in adult brain. Neuroscience 1996;74:1209–1226.
- Conner JM, Lauterborn JC, Yan Q, Gall CM, Varon S: Distribution of brain-derived neurotrophic factor (BDNF) protein and mRNA in the normal adult rat CNS: Evidence for anterograde axonal transport. J Neurosci 1997;17:2295–2313.
- Nawa H, Bessho Y, Carnahan J, Nakanishi S, Mizuno K: Regulation of neuropeptide expression in cultured cerebral cortical neurons by brain-derived neurotrophic factor. J Neurochem 1993;60:772–775.
- Nawa H, Pelleymounter MA, Carnahan J: Intraventricular administration of BDNF increases neuropeptide expression in newborn rat brain. J Neurosci 1994;14:3751–3765.
- Mizuno K, Carnahan J, Nawa H: Brain-derived neurotrophic factor promotes differentiation of striatal GABAergic neurons. Dev Biol 1994;165:243–256.
Article / Publication Details
Published online: September 27, 2000
Issue release date: September 2000
Number of Print Pages: 10
Number of Figures: 6
Number of Tables: 2
ISSN: 0028-3835 (Print)
eISSN: 1423-0194 (Online)
For additional information: https://www.karger.com/NEN
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
Get Permission
PubMed ID
